药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Hexachlorophene
Amiodarone
The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Chlorpheniramine.
Hexachlorophene
Eliglustat
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Eliglustat.
Hexachlorophene
Terodiline
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Terodiline.
Hexachlorophene
Macimorelin
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Macimorelin.
Hexachlorophene
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Deutetrabenazine.
Hexachlorophene
Glasdegib
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Glasdegib.
Hexachlorophene
Ribociclib
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Ribociclib.
Hexachlorophene
Vemurafenib
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Vemurafenib.
Hexachlorophene
Artemether
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Artemether.
Hexachlorophene
Asenapine
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Asenapine.
Hexachlorophene
Romidepsin
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Romidepsin.
Hexachlorophene
Vandetanib
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Vandetanib.
Hexachlorophene
Iloperidone
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Iloperidone.
Hexachlorophene
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Tetrabenazine.
Hexachlorophene
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Zuclopenthixol.
Hexachlorophene
Temafloxacin
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Temafloxacin.
Hexachlorophene
Lithium cation
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Lithium cation.
Hexachlorophene
Paliperidone
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Paliperidone.
Hexachlorophene
Bepridil
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Bepridil.
Hexachlorophene
Sparfloxacin
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Sparfloxacin.